Corcept Therapeutics stockCORT
Corcept Therapeutics trades at $71.63, 43.3% below its 52-week high (Aug 25, 2026). The price is below its 50- and 200-day averages, a downtrend. +105.8% year to date, −6.5% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Mar 2, 2027.
Ratings, candles, signals and the screener for CORT — after you log in
Open the terminalFrequently asked questions about Corcept Therapeutics
What is the Corcept Therapeutics stock price?
At the close on Nov 5, 2026: $71.63 (−9.58% on the day). 52-week high: $126.38 on Aug 25, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Corcept Therapeutics report earnings?
The next quarterly report is on Mar 2, 2027. Last quarter, earnings per share changed +531% year over year, revenue +64%.
Does Corcept Therapeutics pay dividends?
No, Corcept Therapeutics does not pay dividends.
Where does Corcept Therapeutics trade and how to buy it?
Ticker CORT, exchange Nasdaq, listed since 2004. You can buy it through a broker with access to US exchanges.
Should I buy Corcept Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for CORT are in the terminal after you log in.